glaucoma Archives - Insight Presented by Prime Creative Media Thu, 11 Aug 2022 06:16:28 +0000 en-US hourly 1 https://www.insightnews.com.au/wp-content/uploads/2024/02/cropped-Insight-favicon-32x32.png glaucoma Archives - Insight 32 32 Lessons from a glaucoma management clinic https://www.insightnews.com.au/lessons-from-a-glaucoma-management-clinic/ Thu, 05 May 2022 00:33:56 +0000 https://www.insightnews.com.au/?p=27113 Glaucoma Management Clinic
CFEH clinician Janelle Tong with a patient at the Glaucoma Management Clinic.

At the completion of this CPD activity, optometrists will have developed their knowledge of glaucoma management. Including: Understand the structural and functional indices that playRead More

The post Lessons from a glaucoma management clinic appeared first on Insight.

]]> Glaucoma Management Clinic
CFEH clinician Janelle Tong with a patient at the Glaucoma Management Clinic.
At the completion of this CPD activity, optometrists will have developed their knowledge of glaucoma management. Including:
 Understand the structural and functional indices that play
Read More

The post Lessons from a glaucoma management clinic appeared first on Insight.

]]> New five-year data for MIGS device https://www.insightnews.com.au/new-five-year-data-for-migs-device/ Tue, 19 Apr 2022 20:00:47 +0000 https://www.insightnews.com.au/?p=26799
The study enrolled 125 consecutive eyes treated with iStent inject trabecular micro-bypass.

The post New five-year data for MIGS device appeared first on Insight.

]]>
The study enrolled 125 consecutive eyes treated with iStent inject trabecular micro-bypass.
Half a decade of data on the second generation iStent inject has shown a significant reduction in intraocular pressure (IOP) and medication burden in glaucoma patients. While there are more than 200 publications
Read More

The post New five-year data for MIGS device appeared first on Insight.

]]> Aussie study offers new MIGS head-to-head comparison https://www.insightnews.com.au/aussie-study-offers-new-migs-head-to-head-comparison/ Tue, 15 Mar 2022 02:47:19 +0000 https://www.insightnews.com.au/?p=26097 Australia MIGS market
The Glaukos iStent is one of few MIGS procedures reimbursed as a standalone procedure.

The post Aussie study offers new MIGS head-to-head comparison appeared first on Insight.

]]> Australia MIGS market
The Glaukos iStent is one of few MIGS procedures reimbursed as a standalone procedure.
Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no significant difference in intraocular
Read More

The post Aussie study offers new MIGS head-to-head comparison appeared first on Insight.

]]> $300k grant to commercialise Aussie test for assessing glaucoma risk https://www.insightnews.com.au/300k-grant-to-commercialise-test-for-assessing-glaucoma-risk/ Mon, 21 Feb 2022 20:00:38 +0000 https://www.insightnews.com.au/?p=25592
Using a blood or saliva sample, the PRS test can be used to quantify a patient’s genetic risk of glaucoma.

The post $300k grant to commercialise Aussie test for assessing glaucoma risk appeared first on Insight.

]]>
Using a blood or saliva sample, the PRS test can be used to quantify a patient’s genetic risk of glaucoma.
A pioneering solution for assessing glaucoma risk in clinical settings is closer to commercialisation with the support of a $304,000 state government seed grant. South Australian company Seonix
Read More

The post $300k grant to commercialise Aussie test for assessing glaucoma risk appeared first on Insight.

]]> New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed https://www.insightnews.com.au/new-findings-alter-forever-how-we-think-of-migs-dr-ike-ahmed/ Mon, 22 Nov 2021 21:51:29 +0000 https://www.insightnews.com.au/?p=23916 Hydrus Microstent
The findings are said to be a "game changer" for glaucoma.

The post New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed appeared first on Insight.

]]> Hydrus Microstent
The findings are said to be a "game changer" for glaucoma.
Ivantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of visual field loss by 47% versus cataract surgery alone. In what the company
Read More

The post New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed appeared first on Insight.

]]> Glaucoma Australia launches 7 Sights in 7 Days challenge for World Glaucoma Week https://www.insightnews.com.au/glaucoma-australia-launches-7-sights-in-7-days-challenge-for-world-glaucoma-week/ Sun, 14 Nov 2021 23:54:10 +0000 https://www.insightnews.com.au/?p=23792 Glaucoma Australia 7 Sights in 7 Days
Individuals and teams will be prompted to find, snap and share seven ‘sights’ during World Glaucoma Week.

The post Glaucoma Australia launches 7 Sights in 7 Days challenge for World Glaucoma Week appeared first on Insight.

]]> Glaucoma Australia 7 Sights in 7 Days
Individuals and teams will be prompted to find, snap and share seven ‘sights’ during World Glaucoma Week.
Glaucoma Australia (GA) has launched a new initiative encouraging Australians to share a photo of “an amazing sight” every day for seven days to raise funds during World Glaucoma Week (6–12 March
Read More

The post Glaucoma Australia launches 7 Sights in 7 Days challenge for World Glaucoma Week appeared first on Insight.

]]> Alcon to acquire Hydrus Microstent MIGS device for AU$640 million https://www.insightnews.com.au/alcon-to-set-to-acquire-hydrus-microstent-migs-device-for-au640/ Mon, 08 Nov 2021 22:34:52 +0000 https://www.insightnews.com.au/?p=23701
Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

The post Alcon to acquire Hydrus Microstent MIGS device for AU$640 million appeared first on Insight.

]]>
Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.
Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device – for an initial
Read More

The post Alcon to acquire Hydrus Microstent MIGS device for AU$640 million appeared first on Insight.

]]> New glaucoma imaging tech wins 2021 ‘Quinlivan’ Research Grant https://www.insightnews.com.au/new-glaucoma-imaging-tech-wins-2021-quinlivan-research-grant/ Thu, 14 Oct 2021 20:59:36 +0000 https://www.insightnews.com.au/?p=23297 ‘Quinlivan’ Research Grant Professor Ewa Goldys
Prof Ewa Goldys completed her PhD at Warsaw University and is a world-leading biomedical engineer at UNSW.

The post New glaucoma imaging tech wins 2021 ‘Quinlivan’ Research Grant appeared first on Insight.

]]> ‘Quinlivan’ Research Grant Professor Ewa Goldys
Prof Ewa Goldys completed her PhD at Warsaw University and is a world-leading biomedical engineer at UNSW.
A UNSW researcher from the university’s Graduate School of Biomedical Engineering has been awarded Glaucoma Australia (GA)’s ‘Quinlivan’ Research Grant to develop a novel imaging technology for
Read More

The post New glaucoma imaging tech wins 2021 ‘Quinlivan’ Research Grant appeared first on Insight.

]]> Home-based glaucoma management https://www.insightnews.com.au/home-based-glaucoma-management/ Mon, 09 Aug 2021 21:28:33 +0000 https://www.insightnews.com.au/?p=22074

The post Home-based glaucoma management appeared first on Insight.

]]>
Designs For Vision is now supplying the iCare HOME2 tonometer, which it says revolutionises glaucoma care by enabling patients to capture their own intraocular pressure (IOP) at different times of
Read More

The post Home-based glaucoma management appeared first on Insight.

]]> Artificial intelligence: eyecare’s friend of foe? https://www.insightnews.com.au/artificial-intelligence-eyecares-friend-of-foe/ Thu, 10 Jun 2021 21:56:53 +0000 https://www.insightnews.com.au/?p=20926 Eyetelligence system AI
The company's AI technology analyses full-colour fundus images to screen for referable eye diseases.

The post Artificial intelligence: eyecare’s friend of foe? appeared first on Insight.

]]> Eyetelligence system AI
The company's AI technology analyses full-colour fundus images to screen for referable eye diseases.
Eyetelligence is a new Australian-developed AI system helping clinicians screen for three types of eye disease. PROFESSOR MING HE – the clinical expert behind the software – discusses why
Read More

The post Artificial intelligence: eyecare’s friend of foe? appeared first on Insight.

]]>